JPY3,184.00
0.34% today
Tokyo, Nov 26, 07:15 am CET
ISIN
JP3351100007
Symbol
6869
Sector

SYSMEX Stock price

JPY3,194.00
+346.50 12.17% 1M
+498.50 18.49% 6M
+574.67 21.94% YTD
+487.00 17.99% 1Y
-1,621.55 33.67% 3Y
+545.62 20.60% 5Y
+1,511.06 89.79% 10Y
Tokyo, Closing price Tue, Nov 26 2024
-1.00 0.03%
ISIN
JP3351100007
Symbol
6869
Sector

Key metrics

Market capitalization JPY1.99t
Enterprise Value JPY1.96t
P/E (TTM) P/E ratio 37.30
EV/FCF (TTM) EV/FCF 34.44
EV/Sales (TTM) EV/Sales 3.98
P/S ratio (TTM) P/S ratio 4.05
P/B ratio (TTM) P/B ratio 4.52
Dividend yield 0.94%
Last dividend (FY25) JPY30.00
Revenue growth (TTM) Revenue growth 14.47%
Revenue (TTM) Revenue JPY491.29b
EBIT (operating result TTM) EBIT JPY87.57b
Free Cash Flow (TTM) Free Cash Flow JPY56.82b
Cash position JPY91.72b
EPS (TTM) EPS JPY85.66
P/E forward 34.53
P/S forward 3.87
EV/Sales forward 3.80
Show more

Is SYSMEX a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

SYSMEX Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a SYSMEX forecast:

7x Buy
54%
6x Hold
46%

Analyst Opinions

13 Analysts have issued a SYSMEX forecast:

Buy
54%
Hold
46%

Financial data from SYSMEX

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
491,290 491,290
14% 14%
100%
- Direct Costs 228,513 228,513
14% 14%
47%
262,777 262,777
15% 15%
53%
- Selling and Administrative Expenses 105,573 105,573
19% 19%
21%
- Research and Development Expense 31,628 31,628
0% 0%
6%
125,576 125,576
16% 16%
26%
- Depreciation and Amortization 38,004 38,004
14% 14%
8%
EBIT (Operating Income) EBIT 87,572 87,572
17% 17%
18%
Net Profit 53,454 53,454
22% 22%
11%

In millions JPY.

Don't miss a Thing! We will send you all news about SYSMEX directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.

Head office Japan
CEO Hisashi Ietsugu
Employees 10,042
Founded 1968
Website www.sysmex.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today